Environmental Factors Associated With Peripheral Neuropathies in French Guiana
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAdmin CIC
About this trial
Peripheral neuropathies (PN) affect 1% of the global population, particularly the elderly. About 20-30% of cases remain unexplained. In French Guiana, we hypothesize that factors like neurotoxic traditional plant remedies, arboviral disease outbreaks, and mercury exposure from illegal gold mining may contribute to PN. The study aims to assess the association between PN and exposure to arboviral infections, heavy metals, and plant consumption in French Guiana.
Eligibility criteria
Qualifiers
For the Case group: patients diagnosed with diabetic peripheral neuropathy or chronic idiopathic axonal polyneuropathy
For the Control group: patients hospitalized or consulting at the hospitals in Cayenne and Saint-Laurent du Maroni, without peripheral neuropathy.
Disqualifiers
For the Case and Control groups: patients under the age of 18, those who object to participation and those who are unable to complete the questionnaire.
Trial design
Treatments tested in this trial
- Case Group
Treatment groups
78 Participants
are divided into 1 treatment groupSponsors and collaborators
Admin CIC
Lead sponsor
Centre Hospitalier de Cayenne
Sponsor institution
Source ClinicalTrials.gov